Impact evaluation of reactive focal drug administration (rFDA) in northern Senegal

The Senegalese NMCP has been conducting programmatic rFDA in 10 districts in Northern Senegal since 2016/17. For all malaria cases diagnosed at health facilities or by community health workers, a case documentation and a household visit are conducted. During the household visit, all eligible household members receive an antimalarial treatment (rFDA). To evaluate the impact of rFDA on malaria incidence, a quasi-experimental design, with intervention and comparable comparison districts, will be used. A controlled interrupted time series analysis will be conducted with monthly malaria cases from the routine surveillance system as the dependent variable and adjusting for contextual factors (bednet coverage, rainfall, vegetation index, etc).

Quasi-experimental design with controlled interrupted time-series analysis

Health Systems & Op. Research

Apr 2022 — Sep 2022

Senegal

MACEPA IV: Advancing subnational tailoring and impact in priority geographies

Tracking progress against the PMI Insights Research Priorities